Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
However, Novo’s inability to keep up with U.S. demand for Wegovy has effectively delayed the launch in most of Europe.
Source: https://www.shorenewsnetwork.com/2023/09/04/wegovy-makes-uk-weight-loss/
Nevertheless, surging demand for Wegovy, and Novo’s highly effective diabetes drug Ozempic, have sent its shares and earnings to record highs.
Source: https://www.shorenewsnetwork.com/2023/09/04/wegovy-makes-uk-weight-loss/
No assurance can be given that a similar or any mineral resource estimate will be determined at Novo’s Becher Project.
Source: https://www.cbj.ca/novo-progresses-asx-dual-listing-with-lodgement-of-prospectus/
The EMA also raised a thyroid cancer safety signal on several of Novo’s products containing semaglutide in May.
Source: https://qz.com/weight-loss-drugs-ozempic-saxenda-eu-probe-suicide-risk-1850625709
The Pfizer study was smaller than Novo’s late-stage trial and focused on patients with type 2 diabetes.
Source: https://time.com/6281987/weight-loss-pill-semaglutide/